Literature DB >> 23204685

Re. Co. De.: a better classification for determination of still births.

Abha Singh1, Alpana Toppo.   

Abstract

OBJECTIVE: To test the classification system Re. Co. De. to improve our understanding of the main causes associated with fetal deaths.
METHOD: The study included 348 women who were admitted with intrauterine deaths. After the stillborn babies were examined along with the placenta. The causes were classified according to Re. Co. De. system.
RESULTS: The analysis of the new classification (Re. Co. De.) allowed attributable causes to about 90% of cases of stillbirth explained while 10% where unexplained. The commonest cause was found to be toxaemia of pregnancy, followed by IUGR, rupture uterus, obstructed labour, abruptio placentae etc.
CONCLUSION: The Re. Co. De. system gives us a better understanding of antecedents of stillbirth and the clinical practices, which need to be addressed to reduce perinatal mortality and have a better obstetric result in the next pregnancy.

Entities:  

Keywords:  Eclampsia; IUGR; Perinatal mortality; Relevant condition of death; Stillbirth

Year:  2012        PMID: 23204685      PMCID: PMC3307921          DOI: 10.1007/s13224-011-0115-7

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  7 in total

1.  Maternal age and the risk of stillbirth throughout pregnancy in the United States.

Authors:  Uma M Reddy; Chia-Wen Ko; Marian Willinger
Journal:  Am J Obstet Gynecol       Date:  2006-09       Impact factor: 8.661

2.  Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study.

Authors:  Jason Gardosi; Sue M Kady; Pat McGeown; Andre Francis; Ann Tonks
Journal:  BMJ       Date:  2005-10-19

3.  Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth.

Authors:  O Stephansson; P W Dickman; A Johansson; S Cnattingius
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

Review 4.  Genetics and metabolic causes of stillbirth.

Authors:  Ronald J Wapner; Dawnette Lewis
Journal:  Semin Perinatol       Date:  2002-02       Impact factor: 3.300

5.  Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

Authors:  José Villar; Guillermo Carroli; Daniel Wojdyla; Edgardo Abalos; Daniel Giordano; Hassan Ba'aqeel; Ubaldo Farnot; Per Bergsjø; Leiv Bakketeig; Pisake Lumbiganon; Liana Campodónico; Yagob Al-Mazrou; Marshall Lindheimer; Michael Kramer
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

6.  Case-control study of factors associated with intrauterine fetal deaths.

Authors:  Savvas Efkarpidis; Evangelos Alexopoulos; Lucy Kean; David Liu; Toby Fay
Journal:  MedGenMed       Date:  2004-05-27

7.  Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors.

Authors:  Deborah Watson-Jones; Helen A Weiss; John M Changalucha; James Todd; Balthazar Gumodoka; Judith Bulmer; Rebecca Balira; David Ross; Kokungoza Mugeye; Richard Hayes; David Mabey
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

  7 in total
  2 in total

1.  Classification systems for causes of stillbirth and neonatal death, 2009-2014: an assessment of alignment with characteristics for an effective global system.

Authors:  Susannah Hopkins Leisher; Zheyi Teoh; Hanna Reinebrant; Emma Allanson; Hannah Blencowe; Jan Jaap Erwich; J Frederik Frøen; Jason Gardosi; Sanne Gordijn; A Metin Gülmezoglu; Alexander E P Heazell; Fleurisca Korteweg; Joy Lawn; Elizabeth M McClure; Robert Pattinson; Gordon C S Smith; Ӧzge Tunçalp; Aleena M Wojcieszek; Vicki Flenady
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-15       Impact factor: 3.007

2.  Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.

Authors:  Fernanda Tavares Da Silva; Bernard Gonik; Mark McMillan; Cheryl Keech; Stephanie Dellicour; Shraddha Bhange; Mihaela Tila; Diana M Harper; Charles Woods; Alison Tse Kawai; Sonali Kochhar; Flor M Munoz
Journal:  Vaccine       Date:  2016-07-16       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.